3D bioprinting platform creates functional primary and iPSC-derived organoids in alginate-methylcellulose hydrogel for personalized tissue applications.
Injectable, shear-thinning hydrogel using silicate nanoplatelets and heparin enables rapid, tunable, Bioactive protein delivery and biodegrades in 8 weeks.